Options
Heart failure-related atrial fibrillation: A new model for a new prevention strategy?
Journal
Heart Rhythm
Journal Volume
5
Journal Issue
3
Pages
460-461
Date Issued
2008
Author(s)
Wilson L.D.
SDGs
Other Subjects
2,4 thiazolidinedione derivative; angiotensin II; angiotensin receptor; angiotensin receptor antagonist; antiarrhythmic agent; candesartan; hydroxymethylglutaryl coenzyme A reductase inhibitor; peroxisome proliferator activated receptor gamma; peroxisome proliferator activated receptor gamma agonist; pioglitazone; congestive heart failure; disease association; disease exacerbation; drug effect; drug efficacy; drug mechanism; drug safety; editorial; heart atrium fibrillation; heart electrophysiology; heart failure; heart muscle conduction disturbance; heart muscle fibrosis; heart pacing; heart protection; hormone action; human; hypervolemia; mortality; nonhuman; pathophysiology; priority journal; Angiotensin II Type 1 Receptor Blockers; Animals; Atrial Fibrillation; Benzimidazoles; Blotting, Western; Disease Models, Animal; Electrophysiologic Techniques, Cardiac; Fibrosis; Heart Failure; Hypoglycemic Agents; Male; Rabbits; Tetrazoles; Thiazolidinediones
Type
editorial